FASEB J. Uncover Your Biological Pathway
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.06-5763fje.
This Article
Right arrow Summary
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
fj.06-5763fjev1
20/12/2165    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moussa, C. E-H.
Right arrow Articles by Querfurth, H. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moussa, C. E-H.
Right arrow Articles by Querfurth, H. W.
(The FASEB Journal. 2006;20:2165-2167.)
© 2006 FASEB

Transgenic expression of ß-APP in fast-twitch skeletal muscle leads to calcium dyshomeostasis and IBM-like pathology

Charbel E-H. Moussa*, Qinghao Fu*, Pravir Kumar*, Alexander Shtifman*,{ddagger}, Jose R. Lopez{ddagger}, Paul D. Allen{ddagger}, Frank LaFerla{dagger}, David Weinberg*, Jordi Magrane*, Tamar Aprahamian§, Kenneth Walsh§, Kenneth M. Rosen* and Henry W. Querfurth*,1

* Department of Neurology, Caritas St. Elizabeth’s Medical Center, Tufts University School of Medicine, Boston, Massachusetts, USA;

{dagger} Department of Neurobiology and Behaviour, University of California, Irvine, California, USA;

§ Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, Massachusetts, USA; and

{ddagger} Department of Anaesthesia, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA

1Correspondence: Department of Neurology, Caritas St. Elizabeth’s Medical Center of Boston, Tufts University School of Medicine, 736 Cambridge St., CBR419, Boston. MA, USA. E-mail: henry.querfurth{at}tufts.edu

ABSTRACT

Intracellular deposition of the ß-amyloid (Aß) peptide is an increasingly recognized pathological hallmark associated with neurodegeneration and muscle wasting in Alzheimer’s disease (AD) and inclusion body myositis (IBM), respectively. Previous reports have implicated dysregulation of ß-amyloid precursor protein (ßAPP) expression in IBM. Accumulation of full-length ßAPP, its various proteolytic derivatives including Aß, and phospho-tau into vacuolated inclusions is an early pathogenic event. We previously reported on a statistical tendency favoring fast twitch fiber involvement in IBM, reminiscent of the tissue specific patterns of misfolded protein deposition seen in neurodegenerative diseases. To test this principle, we generated an animal model in which human wild-type (WT) ßAPP expression was limited to postnatal type II skeletal muscle. Hemizygous transgenic mice harboring increased levels of holoßAPP751 and Aß in skeletal muscle fibers became significantly weaker with age compared with nontransgenic littermates and exhibited typical myopathic features. A subpopulation of dissociated muscle fibers from transgenic mice exhibited a 2-fold increase in resting calcium and membrane depolarization compared with nontransgenic littermates. Taken together, these data indicate that overexpression of human ßAPP in fast twitch skeletal muscle of transgenic mice is sufficient for the development of some features characteristic of IBM, including abnormal tau histochemistry. The increase in resting calcium and depolarization are novel findings, suggesting both a mechanism for the weakness and an avenue for therapeutic intervention in IBM.—Moussa, C. E-H., Fu, Q., Kumar, P., Shtifman, A., Lopez, J. R., Allen, P. D., LaFerla, F., Weinberg, D., Magrane, J., Aprahamian, T., Walsh, K., Rosen, K. M., Querfurth, H. W. Transgenic expression of ß-APP in fast-twitch skeletal muscle leads to calcium dyshomeostasis and IBM-like pathology.




This article has been cited by other articles:


Home page
J. Neurosci.Home page
M. Kitazawa, V. Vasilevko, D. H. Cribbs, and F. M. LaFerla
Immunization with Amyloid-{beta} Attenuates Inclusion Body Myositis-Like Myopathology and Motor Impairment in a Transgenic Mouse Model
J. Neurosci., May 13, 2009; 29(19): 6132 - 6141.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
X. Chen, O. Ghribi, and J. D. Geiger
Rabbits fed cholesterol-enriched diets exhibit pathological features of inclusion body myositis
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2008; 294(3): R829 - R835.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. Fonte, D. R. Kipp, J. Yerg III, D. Merin, M. Forrestal, E. Wagner, C. M. Roberts, and C. D. Link
Suppression of in Vivo -Amyloid Peptide Toxicity by Overexpression of the HSP-16.2 Small Chaperone Protein
J. Biol. Chem., January 11, 2008; 283(2): 784 - 791.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
C. C. Weihl, S. E. Miller, P. I. Hanson, and A. Pestronk
Transgenic expression of inclusion body myopathy associated mutant p97/VCP causes weakness and ubiquitinated protein inclusions in mice
Hum. Mol. Genet., April 15, 2007; 16(8): 919 - 928.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by The Federation of American Societies for Experimental Biology.